Hegne, Germany

Wolfgang Schoetensack


Average Co-Inventor Count = 2.4

ph-index = 3

Forward Citations = 62(Granted Patents)


Location History:

  • Konstanz, DE (1976)
  • Constance, DE (1978)
  • Hegne, DE (1976 - 1980)

Company Filing History:


Years Active: 1976-1980

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Wolfgang Schoetensack: Innovator in Pharmaceutical Chemistry

Introduction

Wolfgang Schoetensack is a notable inventor based in Hegne, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work primarily focuses on the development of novel compounds with various therapeutic applications.

Latest Patents

Schoetensack's latest patents include compositions of and new uses for N-acylanilinobutyric acids. These pharmaceutically acceptable compositions contain at least one N-acylanilinobutyric acid, which has uses unrelated to the choleretic activity suggested in U.S. Pat. No. 3,780,095. The new applications generally involve administering smaller doses than would be required to obtain a choleretic effect. Notable new uses include increasing gastrointestinal enzyme secretion and tonicizing the cardiovascular system. The increase in gastrointestinal enzyme secretion is beneficial in treating various diseases, such as sprue, indigestion, acute and chronic pancreatitis, and stomach ulcers. The tonicizing of the cardiovascular system aids in increasing blood circulation in internal organs and treating disturbances in liver function. Additionally, he has developed aryl-substituted piperazinyl-alkylamino-uracils and their corresponding uracil ethers, which are useful for lowering blood pressure and providing analgesic, sedative, or antihistaminic effects in mammals.

Career Highlights

Throughout his career, Schoetensack has worked with prominent companies, including Byk Gulden Lomberg Chemische Fabrik GmbH and Byk Gulden Lomberg Chemische Fabrik Gesellschaft mit beschränkter Haftung. His innovative work has led to advancements in pharmaceutical formulations and therapeutic applications.

Collaborations

Schoetensack has collaborated with notable colleagues, including Kurt Klemm and Richard Riedel. These partnerships have contributed to the development of his patented inventions and have enhanced the impact of his work in the pharmaceutical industry.

Conclusion

Wolfgang Schoetensack is a distinguished inventor whose contributions to pharmaceutical chemistry have led to significant advancements in therapeutic applications. His innovative patents and collaborations reflect his commitment to improving healthcare through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…